NICE unable to endorse new treatment for prostate cancer | Northern Ireland Cancer Network website

Increase text | Decrease text | Print page

NICE unable to endorse new treatment for prostate cancer

12 Jan 2012

NICE, the healthcare guidance body, has today published final draft guidance not recommending cabazitaxel (Jevtana, Sanofi) in combination with prednisone or prednisolone as a second line treatment for prostate cancer.

Please click here to read the 'NICE' press release in full

Featured items

The role of the NI Cancer Registry
Page
Service Framework for Cancer Prevention, Treatment & Care
Page
Patient Information Pathways
Page
Referral Guidance for Suspected Cancer
Page
Patient Information learning and development
Course/Programme
Priority for Action Target 4 Ensuring Fully Integrated Palliative Care - Definitons and Monitoring Guidance Paper
Publication/Resource
Management of patients who become ill within 6 weeks of Chemotherapy - Nov 09
Publication/Resource
NICaN Patient Information Project
Page
Guidance for HSC staff providing information to people affected by cancer
Page
End of life care: New guidance from the GMC
Publication/Resource
Evaluation Report - NICaN Brief Holistic Assessment Tool Pilot Project (May 2010)
Publication/Resource
Share your cancer story (Narratives Project)
Webform
Post Cancer Treatment Follow Up
Publication/Resource
Neutropenic Sepsis Guidelines - NICaN
Publication/Resource
Cancer screening in Northern Ireland (bowel, breast and cervical)
Link
www.pallcareni.net - the website for NI Supportive & Palliative Care Network
Link
March is Ovarian Cancer Awareness Month
News article
March is Prostate Cancer Awareness Month
News article
NICaN Nurse Director becomes Fellow of Royal College of Nursing
News article

Click here to view all featured items.

Information for Cancer Patients about seasonal flu and chemotherapy can be accessed here

Print this page